Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2010
12/29/2010CN101445504B Dioxane-2-alkyl carbamates derivatives
12/29/2010CN101422505B Foot-and-mouth disease vaccine and immunological stress resistance agent of other livestock and poultry and use thereof
12/29/2010CN101214270B Acanthopanax senticosus effective fraction extract, preparation and application thereof
12/29/2010CN101205234B Curcumin-zinc compound as well as solid dispersion preparation and uses thereof
12/29/2010CN101200465B Decahydronaphthalene compounds and medical uses thereof
12/29/2010CN101098702B Drugs, food or drink for improving pancreatic functions
12/29/2010CN101057661B Extraction method for alpha-linolenic acid and preparation
12/29/2010CN101019598B Cold drink product capable of improving intestinal tract function
12/29/2010CA2765988A1 Novel compound useful for the treatment of degenerative and inflammatory diseases
12/29/2010CA2764860A1 Multimeric polypeptides of hla-g including at least two alpha3 domains and pharmaceutical uses thereof
12/29/2010CA2764475A1 Crystals
12/28/2010USRE42014 Pharmaceutical compositions
12/28/2010US7858824 Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing them
12/28/2010US7858765 OX40R binding agents
12/28/2010US7858746 recognize selectively both Programmed Death 1 (PD-1) protein and a membrane protein co-existing with PD-1 on a cell membrane, and can transmit a suppressive signal of PD-1; for medical treatment and/or prevention of diseases caused by immune abnormality
12/28/2010US7858738 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
12/28/2010US7858589 A saponin possessing immune adjuvant activity, derived from Quillaja saponaria; an immunostimulatory oligonucleotide cotaining an unmethylated CpG dinucleotide,wherein the immunostimulatory oligonucleotide is not a part of a DNA vaccine vector
12/28/2010US7858368 Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars
12/28/2010US7858094 Controling abberant inflamatory response; obtain animal, incubate with modulator of inflammation, monitor animal for adjustment in inflammatory response
12/23/2010WO2010148234A1 Sap variants and their use
12/23/2010WO2010148223A2 Anti-vegf antibodies and their uses
12/23/2010WO2010147898A2 Small molecule inhibitors of spleen tyrosine kinase (syk)
12/23/2010WO2010147449A1 Adaptogenic activity of labisia pumila extract
12/23/2010WO2010147387A2 Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides as active ingredients
12/23/2010WO2010147117A1 Peptide and use thereof
12/23/2010WO2010146622A1 Nfat signal inhibitor and calcineurin inhibitor
12/23/2010WO2010146236A1 Urea substituted sulphonamide derivatives
12/23/2010WO2010146171A1 Novel manner of administering allergen in allergen specific immunotherapy
12/23/2010WO2010146133A1 Heterocyclylaminopyrimidines as kinase inhibitors
12/23/2010WO2010146132A1 Sulfonamides and sulfamides as zap-70 inhibitors
12/23/2010WO2010145203A1 1,2,4-oxadiazol derivatives, their pharmaceutical compositions and their use as sphingosine 1-phosphate 1 receptor agonists
12/23/2010WO2010145202A1 Thiazole or thiadizaloe derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists
12/23/2010WO2010145201A1 Compounds
12/23/2010WO2010145017A1 Stimulation of innate immunity with an antigen from bacterial origin
12/23/2010WO2009097394A3 Methods for modulating a population of myeloid-derived suppressor cells and uses thereof
12/23/2010US20100325744 Non-glycosylated recombinant monovalent antibodies
12/23/2010US20100324829 Method of selecting hla-dp4 ligands and the applications thereof
12/23/2010US20100324093 Ccr9 inhibitors and methods of use thereof
12/23/2010US20100324089 Anti-inflammatory composition
12/23/2010US20100324082 ENANTIOMERIC COMPOSITIONS OF 2-AMINO-1-(2-ISOPROPYLPYRAZOLO[1,5-a]PYRIDIN-3-YL)PROPAN-1-ONE AND RELATED METHODS
12/23/2010US20100324062 Compounds and compositions as protein kinase inhibitors
12/23/2010US20100324050 Inhibitors of bruton's tyrosine kinase
12/23/2010US20100323999 Therapeutic Molecules and Methods-1
12/23/2010US20100323990 Ship 1 modulator prodrugs
12/23/2010US20100323980 Improvements to analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation
12/23/2010US20100323970 Sap variants and their use
12/23/2010US20100323969 Compounds Binding to P-Selectin
12/23/2010US20100323967 RNA Antagonist Compounds for the Modulation of MCL-1
12/23/2010US20100323964 New non-selective somatostatin analogues
12/23/2010US20100323950 Use of beta-melanotropin as a therapeutic agent, eg for the treatment of aids or alzheimer
12/23/2010US20100323024 Puumala virus full-length m segment-based dna vaccines
12/23/2010US20100322997 Method for producing biologically ingestible microparticles, biologically ingestible microparticles, and dispersion and pharmaceutical composition containing the same
12/23/2010US20100322978 Medical composition
12/23/2010US20100322977 Biomaterials, compositions, and methods
12/23/2010US20100322976 Tonic and food supplement comprising aloe vera and honey
12/23/2010US20100322974 Targeting the histone code as a bacterial strategy for selectively modulating gene expression
12/23/2010US20100322973 Anti-allergic agent
12/23/2010US20100322972 HCV Vaccines For Chronic HCV Patients
12/23/2010US20100322971 Method for producing vaccinal viral strain of a virus of the reoviridae family
12/23/2010US20100322970 Modified influenza virus
12/23/2010US20100322966 Method for allogeneic cell therapy
12/23/2010US20100322965 Viral vaccine vectors
12/23/2010US20100322964 Bacterial composition and its use
12/23/2010US20100322959 Immunogenic composition
12/23/2010US20100322958 Modified saccharides
12/23/2010US20100322957 Secretion-related bacterial proteins for nlrc4 stimulation
12/23/2010US20100322956 Methods and substances for the treatment of alzheimer's
12/23/2010US20100322952 Compositions for and methods of enhancing the immune response to antigens
12/23/2010US20100322941 Human Anti-IP-10 Antibodies Uses Thereof
12/23/2010US20100322940 In vitro modification of glycosylation patterns of recombinant glycopeptides
12/23/2010US20100322936 Lm-1 antibodies, functional fragments, lm-1 target antigen, and methods for making and using same
12/23/2010US20100322931 Anti-vegf antibodies and their uses
12/23/2010US20100322928 Methods of diagnosing, monitoring treatment and treating systemic lupus erythematosus (sle)
12/23/2010US20100322927 Glycosylated antibodies
12/23/2010US20100322920 Human monoclonal antibodies against CD30
12/23/2010US20100322913 Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest
12/23/2010US20100322895 T cell depleting compositions useful for treating cancer
12/23/2010US20100322894 Combination Therapies for Treating Type 1 Diabetes
12/23/2010US20100322893 Ctla-4 protein variants
12/23/2010CA2765755A1 Anti-vegf antibodies and their uses
12/23/2010CA2765534A1 Small molecule inhibitors of spleen tyrosine kinase (syk)
12/23/2010CA2765448A1 Stimulation of innate immunity with an antigen from bacterial origin
12/23/2010CA2765394A1 Sap variants and their use
12/23/2010CA2763730A1 Heterocyclylaminopyrimidines as kinase inhibitors
12/23/2010CA2763720A1 Sulfonamides and sulfamides as zap-70 inhibitors
12/23/2010CA2761568A1 Structured viral peptide compositions and methods of use
12/22/2010EP2264178A1 Vaccinia virus host range genes to increase the titer of Avipoxviruses
12/22/2010EP2264173A2 Use of a double-stranded ribonucleic acid for targeted inhibition of the expression of a given target gene
12/22/2010EP2264072A1 Enhancement of antibody-mediated cytotoxicity.
12/22/2010EP2264059A1 Polypeptides, cDNAs encoding the same and utilization thereof
12/22/2010EP2264034A1 Bicyclic pyrrole compound
12/22/2010EP2264033A1 3,5-DIPHENYL-SUBSTITUTED PYRROLO[2,3b]PYRIDINES USEFUL AS KINASE INHIBITORS
12/22/2010EP2264030A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
12/22/2010EP2264029A1 1,3-dihydroisobenzofuran derivative
12/22/2010EP2264028A1 Pyrazole compounds useful as protein kinase inhibitors
12/22/2010EP2263709A1 Medical device having hydration inhibitor
12/22/2010EP2263697A2 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
12/22/2010EP2263669A1 Pharmaceutically active isoindoline derivatives
12/22/2010EP2263664A1 Opioid receptors stimulating compounds (thymoquinone, Nigella sativa) and food allergy
12/22/2010EP2263652A1 Aerosols comprising nanoparticle drugs
1 ... 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 ... 1172